M&A Deal Summary

Abbott Laboratories Acquires Ibis Biosciences

On January 6, 2009, Abbott Laboratories acquired life science company Ibis Biosciences from Ionis for 175M USD

Acquisition Highlights
  • This is Abbott Laboratories’ 5th transaction in the Life Science sector.
  • This is Abbott Laboratories’ 26th largest (disclosed) transaction.
  • This is Abbott Laboratories’ 12th transaction in the United States.
  • This is Abbott Laboratories’ 4th transaction in California.

M&A Deal Summary
Date 2009-01-06
Target Ibis Biosciences
Sector Life Science
Buyer(s) Abbott Laboratories
Sellers(s) Ionis
Deal Type Add-on Acquisition
Deal Value 175M USD

Target

Ibis Biosciences

Carlsbad, California, United States
Ibis Biosciences, Inc. is a molecular diagnostics business.

Search 199,713 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abbott Laboratories

North Chicago, Illinois, United States
Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 40.1B USD (2023)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. Abbott Laboratories was incorporated in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 14 of 35
Sector (Life Science) 5 of 11
Type (Add-on Acquisition) 14 of 35
State (California) 4 of 14
Country (United States) 12 of 27
Year (2009) 1 of 5
Size (of disclosed) 26 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-10-16 Abbott Spine

Austin, Texas, United States

Abbott Spine is an innovator in spinal implant technology. We offer a broad range of industry-leading and technologically advanced devices for neck and back surgery. In addition to our diversified spinal fusion product line, we develop next-generation technologies that are less invasive and intervene earlier in a patient’s continuum of care. Our mission is to work with surgeons and specialists worldwide to advance the art and science of spine surgery.

Sell $360M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-01-12 Advanced Medical Optics

Santa Ana, California, United States

Advanced Medical Optics Inc. (AMO) offers a range of refractive technologies for myopia, hyperopia, astigmatism, presbyopia, cataract, spherical aberration and corneal health.

Buy $2.8B

Seller(S) 1

SELLER

Ionis

Carlsbad, California, United States
Category Company
Founded 1989
Sector Life Science
Employees927
Revenue 788M USD (2023)
DESCRIPTION

Ionis is a drug development programs are focused on treating cardiovascular and metabolic diseases. Ionis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ionis was founded in 1989 and is based in Carlsbad, California.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2009) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-09-27 Symphony GenIsis

Rockville, Maryland, United States

Symphony GenIsis, Inc. is a biopharmaceutical company, develops cholesterol-lowering and diabetic drugs.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-08-31 Akcea Therapeutics

Boston, Massachusetts, United States

Akcea Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing medicines to treat patients with serious and rare diseases.

Buy -
Mergr

Product

Company

Legal